Aduro BioTech, Inc. (ADRO) Stock: Here’s What’s Happening


Aduro BioTech, Inc. (ADRO) is trending up in the market today. The company, focused in the biotechnology sector, is currently priced at $1.05 after gaining 0.00% so far in today’s session. As it relates to biotechnology stocks, there are quite a few aspects that have the ability to generate movement in the market. News is one of the most common reasons for movement. Here are the recent trending headlines centered around ADRO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-02-19 04:05PM Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)
Sep-30-19 04:05PM Aduro Biotech to Present at the 2019 Cantor Global Healthcare Conference
Sep-19-19 09:49AM Do Insiders Own Lots Of Shares In Aduro BioTech, Inc. (NASDAQ:ADRO)?
Sep-04-19 08:30AM Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Sep-03-19 04:05PM Aduro Biotech to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Nonetheless, any time investors are making an investing decision, prospective investors should look into much more than news, especially in the speculative biotech sector. Here’s what’s happening with Aduro BioTech, Inc..

How ADRO Has Been Trending

Although a single session gain, like the gain that we’re seeing from Aduro BioTech, Inc. may cause excitement in some investors, a single session move by itself shouldn’t be the reason for a decision to, or not to, invest in a company. It’s always a good idea to take a look at trends further out than a single trading session. In the case of ADRO, here are the trends that investors have seen:

  • Past 7 Days – Over the past seven days, ADRO has produced a change in value amounting to 9.38%.
  • Past Month – The monthly returns from Aduro BioTech, Inc. works out to -22.22%.
  • Past 3 Months – Throughout the last quarter, the stock has generated a ROI of -29.53%
  • Bi-Annually – Throughout the last six months, we have seen a change that works out to -72.15% from the company.
  • YTD – Since the close of last year ADRO has produced a return on investment of -60.23%.
  • Annually – Lastly, throughout the last year, we’ve seen a change of -83.90% from ADRO. Throughout this period, the stock has traded at a high of -84.87% and a low price of 14.13%.

Key Ratios

Digging into various ratios associated with a company can give investors a look of how dangerous and/or potentially profitable a an investment option might be. Below are a few of the important ratios to think about when digging into ADRO.

Short Ratio – The short ratio is a measure of short interest. As the ratio goes higher, it shows that more investors are expecting that the stock is headed for declines. Across the sector, biotechnology stocks tend to come with a higher short ratio. However, we also see quite a few short squeezes in the industry. Nonetheless, when it comes to Aduro BioTech, Inc., it’s short ratio clocks in at 3.53.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Basically, they measure the company’s abilities to pay for its debts when they mature using quick assets or current assets. In the biotechnology space, many companies are heavily reliant on the continuation of investor support, the quick and current ratios can look damning. However, some gems in the biotechnology industry come with positive current and quick ratios. As far as ADRO, the quick and current ratios add up to 8.40 and 8.40 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets owned by the company. In this case, that ratio equates to 1.26.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is a very important ratio to look into. In this case, the cash to share value ratio works out to 3.31.

Analyst Opinions With Regard To Aduro BioTech, Inc.

Although it’s rarely a good idea to blindly follow the thoughts of analysts, it is a smart idea to consider their opinions when validating your own opinions before making investment decisions in the biotechnology space. Here are the recent moves that we’ve seen from analysts as it relates to ADRO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-03-19 Downgrade Oppenheimer Outperform → Perform
Apr-15-19 Initiated SVB Leerink Outperform $9
Feb-22-18 Initiated Cantor Fitzgerald Overweight $15
Dec-13-17 Reiterated H.C. Wainwright Buy $18 → $9.50
May-01-17 Initiated Rodman & Renshaw Buy $18

What Are Big Money Players Doing With Aduro BioTech, Inc.

An interesting fact I’ve come to understand so far in my brief period on Earth is that smart investors tend to follow the moves made by big money. In general, investors that want to play it relatively safe will keep an eye on investments made by institutional investors as well as insiders of the company. So, is big money flowing in regard to ADRO? Here’s the information:

Institutions own 47.50% of the company. Institutional interest has moved by 0.05% over the past three months. When it comes to insiders, those who are close to the company currently own 1.50% percent of ADRO shares. Institutions have seen ownership changes of an accumulative -6.98% over the last three months.

A Look At Share Counts

Traders and investors seem to like to know the total numbers of shares both available and outstanding. As far as Aduro BioTech, Inc., currently there are 76.14M with a float of 54.68M. These numbers mean that of the total of 76.14M shares of ADRO in existence today, 54.68M are able to be traded in the public realm.

I also like to look at the short float. After all, if a high percentage of the float available for trading is sold short, the overall opinion among traders is that the stock is headed for a steep decline. In regard to ADRO, the short percentage of the float is currently 2.89%. Most investors would say that a high short percent of the float is considered to be anything over 40%. Nonetheless, I’ve found that a short ratio over 26% is likely a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from ADRO in terms of financial results?Here’s the data:

  • Analyst Expectations – As it stands at the moment, Wall Street analysts expect that the company will come up with EPS of -0.84, with -0.23 being reported in the earnings announcement for the current quarter. Although this information isn’t earnings driven, since we are talking about analysts, the stock is presently rated a 1.70 when rated on a scale from 1 to 5 on which 1 is the poorest possible analyst rating and 5 is the best possible rating.
  • 5-Year Sales – In the last 5 years, Aduro BioTech, Inc. has announced a movement in sales volume in the amount of 78.70%. EPS over the period have seen a change of -36.20%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in today’s society, ADRO has generated a change in earnings that amounts to 25.00%. The company has also experienced a change when it comes to sales volume that adds up to 88.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play an important part in my ability to learn. Sure, I can look through social trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you’d like to help me learn something, I would love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at something? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here